Development and evaluation of inhalable particles containing kanamycin monosulphate and pyrazinoic acid for the treatment of drug resistant tuberculosis
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
newline